சிட்ரின் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சிட்ரின் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சிட்ரின் மருந்து Today - Breaking & Trending Today

Diurnal (AIM:DNL) | RNS | Diurnal Group PLC - Agreement with Citrine Medicine for Efmody


$1.0 million and will receive
$28.75 million in additional cash payments upon achievement of certain regulatory milestones and sales milestones based on annual sales thresholds. Diurnal will also receive tiered royalties on sales ranging from low to mid double-digits.
 
Citrine is a therapeutics platform company focused on the
Greater China market that was co-founded by Vivo Capital, F-Prime Capital and Eight Roads Ventures. Citrine is focused on creating a therapeutic platform to deliver rare disease drugs to the Chinese market and to develop the first ever rare disease ecosystem in the country. The Company signed an original licensing agreement with Citrine in ....

United Kingdom , Hong Kong , Melissa Bradford Klug , Foster Mitchell , Emma Earl , Freddy Crossley , Martin Whitaker , Richard Bungay , Alex Davis , Rupert Dearden , Simon Conway , Citrine Medicine Inc , Panmure Gordon United Kingdom Limited Nominated Adviser , Diurnal Group , Citrine Medicine , Vivo Capital , F Prime Capital , Eight Roads , Chief Business Officer , Medical Screening , Chief Executive , Chief Financial , Nominated Adviser , Sole Broker , Investor Relations , Congenital Adrenal Hyperplasia ,